MedPath

Mortality After Endoscopic Retrograde Cholangiopancreatography

Completed
Conditions
Cholangiopancreatography, Endoscopic Retrograde
Deep Sedation
Mortality
Registration Number
NCT02983331
Lead Sponsor
Gulsah Karaoren
Brief Summary

In this study, the investigators aimed to overview patients with specific and non-specific complications who admitted to intensive care unit following endoscopic retrograde cholangiopancreatography and had fatal course in the facility

Detailed Description

The investigators retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol (midazolam 0.02 mgkg-1; fentanyl, 1 mgkg-1; propofol 1 mgkg-1) between 2011 and 2016 after approval of local ethics committee of Umraniye Training Hospital.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1471
Inclusion Criteria
  • Patients who underwent elective or emergent ERCP at semi-prone position with routine monitoring and standard sedation protocol
Exclusion Criteria
  • Patients who discharged to ward after treatment and follow-up in ICU

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of anaesthesia related mortality of the endoscopic retrograde cholangiopancreatographyprocedure under sedation5 years

We identified patients who developed complications during procedure and admitted to intensive care unit (ICU).

Number of Participants With endoscopic retrograde cholangiopancreatography Related complications5 years

We retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol

Secondary Outcome Measures
NameTimeMethod
Value of Acute Physiology and Chronic Health Evaluation (APACHE II) score for predicting mortality5 years
Value of Charlson comorbidity index (CCI) score for predicting mortality5 years

Trial Locations

Locations (1)

Istanbul Umraniye Training Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath